Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neuroectodermal Tumors, Primitive 1Neuroectodermal Tumors 1Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 20Etoposide 19Temozolomide 16Carboplatin 16Filgrastim 15Vincristine 11Cisplatin 11Radiotherapy 10Thiotepa 9Melphalan 8Granulocyte Colony-Stimulating Factor 8etoposide phosphate 7Lomustine 7Peripheral Blood Stem Cell Transplantation 6Radiation 5Methotrexate 5Magnetic Resonance Spectroscopy 5Topotecan 4Mesna 4Gemcitabine 4Busulfan 4sargramostim 3gallium Ga 68 dotatate 3Thalidomide 3Stem Cell Transplantation 3Irinotecan 3Ifosfamide 3Donepezil 3Celecoxib 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Medulloblastoma × Maintenance Chemotherapy × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed
33 enrolled
CNS

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡